Here's Why Conmed (CNMD) is a Strong Growth Stock

The article details Zacks Style Scores (Value, Growth, Momentum, and VGM), which complement the Zacks Rank to identify stocks with high outperformance potential, noting Zacks #1 ranked stocks have historically yielded a +23.75% average annual return since 1988. CONMED (CNMD), a medical products manufacturer, is presented as a strong growth candidate despite its Zacks #3 (Hold) rank, underscored by an 'A' VGM score, 'B' Growth score, 7% forecasted earnings growth for the current fiscal year, recent upward analyst revisions for FY2025, and a consistent +9.2% average earnings surprise, positioning it for investors' short lists.

Analysis

CONMED Corporation (CNMD) presents a mixed but compelling profile according to the provided analyst ratings. While carrying a neutral Zacks Rank #3 (Hold), the company exhibits strong underlying growth characteristics, as evidenced by a top-tier 'A' VGM Score and a 'B' Growth Style Score. This optimism is supported by a forecast for 7% year-over-year earnings growth in the current fiscal year. Furthermore, analyst sentiment for the forward-looking fiscal 2025 period is turning positive, with two upward earnings estimate revisions in the last 60 days, lifting the consensus estimate by $0.04 to $4.46 per share. The company's operational execution is historically robust, demonstrated by an average positive earnings surprise of 9.2%, suggesting a consistent ability to outperform market expectations. These factors combined indicate that despite the neutral headline rating, fundamental growth drivers and positive estimate momentum position CNMD as a noteworthy candidate for investors focused on growth.

Key Decisions for Investors

• Growth-oriented investors should consider adding CNMD to their watchlist, given its strong growth scores and positive forward-looking analyst revisions.
• Investors should monitor upcoming earnings announcements for confirmation of the forecasted 7% growth and watch for any potential upgrade from its current Zacks #3 (Hold) rank, which would serve as a significant positive catalyst.
• Note the company's consistent track record of delivering an average earnings surprise of +9.2%, which may indicate a pattern of conservative guidance and potential for upside during future earnings reports.